NEW YORK (Reuters) - Mylan N.V.'s emergency allergy antidote EpiPen is in short supply in Canada and Britain, but remains available in the United States, the treatment's manufacturer said on Friday.

Allergy sufferers are being advised to take extra precautions around their health, due to an EpiPen shortage in the UK. The adrenaline jab’s manufacturer Mylan announced it is experiencing supply ...

On Thursday, amid mounting pressure from the public and politicians alike, the drug company that makes EpiPens finally promised to do something about their often astronomical price. The company is ...

People who carry EpiPens have been warned of a potentially lethal 'malfunction' that is easily preventable. Dr Bhavini Shah, GP at LloydsPharmacy Online Doctor, explained how EpiPens must be stored ...

FILE PHOTO: EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016. REUTERS/Jim ...